McKesson Corporation (0JZU.L)
USD 705.49
(-0.86%)
USD 705.49
(-0.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 889 Million USD | 8.68% |
| 2022 | 2.61 Billion USD | -27.47% |
| 2021 | 3.6 Billion USD | 19.87% |
| 2020 | 3 Billion USD | -44.13% |
| 2019 | 5.38 Billion USD | 16.73% |
| 2018 | 4.61 Billion USD | -11.41% |
| 2017 | 5.2 Billion USD | -6.36% |
| 2016 | 5.56 Billion USD | 36.79% |
| 2015 | 4.06 Billion USD | -9.7% |
| 2014 | 4.5 Billion USD | -29.66% |
| 2013 | 6.4 Billion USD | 164.87% |
| 2012 | 2.41 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 3.14 Billion USD | 83.03% |
| 2023 Q1 | 4.78 Billion USD | 82.95% |
| 2023 Q4 | 2.8 Billion USD | -50.13% |
| 2023 Q3 | 5.62 Billion USD | 17.38% |
| 2023 Q2 | 4.79 Billion USD | 0.13% |
| 2023 FY | 2.8 Billion USD | 7.22% |
| 2022 FY | 2.61 Billion USD | -27.47% |
| 2022 Q3 | 5.39 Billion USD | 25.63% |
| 2022 Q2 | 4.29 Billion USD | -15.63% |
| 2022 Q1 | 5.09 Billion USD | 41.17% |
| 2022 Q4 | 2.61 Billion USD | -51.53% |
| 2021 Q2 | 5.4 Billion USD | -21.9% |
| 2021 Q1 | 6.92 Billion USD | 130.01% |
| 2021 FY | 3.6 Billion USD | 19.87% |
| 2021 Q3 | 4.85 Billion USD | -10.19% |
| 2021 Q4 | 3.6 Billion USD | -25.69% |
| 2020 Q2 | 6.25 Billion USD | -3.65% |
| 2020 Q3 | 5.75 Billion USD | -7.97% |
| 2020 Q4 | 3 Billion USD | -47.7% |
| 2020 FY | 3 Billion USD | -44.13% |
| 2020 Q1 | 6.48 Billion USD | 28.83% |
| 2019 FY | 5.38 Billion USD | 16.73% |
| 2019 Q3 | 9.6 Billion USD | 11.61% |
| 2019 Q4 | 5.03 Billion USD | -47.57% |
| 2019 Q1 | 7.61 Billion USD | 63.17% |
| 2019 Q2 | 8.6 Billion USD | 13.06% |
| 2018 Q3 | 8 Billion USD | 12.72% |
| 2018 FY | 4.61 Billion USD | -11.41% |
| 2018 Q1 | 7.67 Billion USD | 41.22% |
| 2018 Q2 | 7.09 Billion USD | -7.57% |
| 2018 Q4 | 4.66 Billion USD | -41.69% |
| 2017 Q3 | 6.33 Billion USD | 7.61% |
| 2017 Q4 | 5.43 Billion USD | -14.22% |
| 2017 FY | 5.2 Billion USD | -6.36% |
| 2017 Q1 | 5.63 Billion USD | -2.13% |
| 2017 Q2 | 5.89 Billion USD | 4.45% |
| 2016 Q1 | 3.45 Billion USD | -15.29% |
| 2016 Q4 | 5.76 Billion USD | -13.86% |
| 2016 Q3 | 6.68 Billion USD | 153.08% |
| 2016 FY | 5.56 Billion USD | 36.79% |
| 2016 Q2 | 2.64 Billion USD | -23.41% |
| 2015 FY | 4.06 Billion USD | -9.7% |
| 2015 Q4 | 4.07 Billion USD | -23.31% |
| 2015 Q3 | 5.31 Billion USD | 31.84% |
| 2015 Q2 | 4.02 Billion USD | -3.17% |
| 2015 Q1 | 4.16 Billion USD | -7.59% |
| 2014 Q1 | 6.56 Billion USD | 2.59% |
| 2014 Q4 | 4.5 Billion USD | -22.46% |
| 2014 Q3 | 5.8 Billion USD | -14.2% |
| 2014 Q2 | 6.76 Billion USD | 3.05% |
| 2014 FY | 4.5 Billion USD | -29.66% |
| 2013 Q1 | 1.96 Billion USD | -18.54% |
| 2013 Q2 | 1.91 Billion USD | -2.79% |
| 2013 Q3 | 2.44 Billion USD | 27.64% |
| 2013 Q4 | 6.4 Billion USD | 162.05% |
| 2013 FY | 6.4 Billion USD | 164.87% |
| 2012 Q4 | 2.41 Billion USD | 188.66% |
| 2012 Q3 | -2.72 Billion USD | 0.0% |
| 2012 FY | 2.41 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 1276.907% |
| Accuray Incorporated | 103.58 Million USD | -758.224% |
| Align Technology, Inc. | -840.47 Million USD | 205.774% |
| Elevance Health Inc. | 18.59 Billion USD | 95.219% |
| AxoGen, Inc. | 32.26 Million USD | -2655.222% |
| Boston Scientific Corporation | 8.23 Billion USD | 89.201% |
| CVS Health Corporation | 71.18 Billion USD | 98.751% |
| Cardinal Health, Inc. | 476 Million USD | -86.765% |
| Centene Corporation | 506 Million USD | -75.692% |
| DaVita Inc. | 10.65 Billion USD | 91.654% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 97.828% |
| Hologic, Inc. | 374.4 Million USD | -137.447% |
| Humana Inc. | 5.51 Billion USD | 83.892% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -79.978% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 83.59% |
| Masimo Corporation | 804 Million USD | -10.572% |
| Patterson Companies, Inc. | 648.47 Million USD | -37.09% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 81.016% |
| ResMed Inc. | 635.57 Million USD | -39.874% |
| Henry Schein, Inc. | 2.57 Billion USD | 65.409% |
| Teladoc Health, Inc. | 468.6 Million USD | -89.713% |
| Universal Health Services, Inc. | 5.24 Billion USD | 83.058% |
| Veeva Systems Inc. | -647.71 Million USD | 237.252% |
| Baxter International Inc. | 11.16 Billion USD | 92.038% |
| Becton, Dickinson and Company | 14.46 Billion USD | 93.853% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 133.417% |
| Danaher Corporation | 13.49 Billion USD | 93.411% |
| Stryker Corporation | 10.02 Billion USD | 91.131% |
| Medtronic plc | 23.67 Billion USD | 96.246% |